BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Eukarion Incorporated

Eukarion's protein modification program is directed at blocking the function of intracellular disease-associated targets using modified LipoclonalŪ antibodies. The modification enables their passage across blood vessel walls and cellular membranes and, thus, their entry into cells to block their selected target.


Contact Details:
6F Alfred Circle
Bedford
MA
01730
United States of America
Tel:781 275 0424
Fax:781 275 0752
Email:mail@eukarion.com
WWW:

www.eukarion.com/




Loading...

Recent Publications by Eukarion Incorporated:

Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease.
Exposure of mice to the herbicide paraquat has been demonstrated to result...
24th September, 2005
Buck Institute for Age Research, Novato, California 94945 and Eukarion, J Biol Chem. 2005 Aug 12;280(32):29194-8. Epub 2005 Jun 9.
DOI Direct Link
Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies.
Synthetic catalytic scavengers of reactive oxygen species (ROS) may have...
22nd October, 2002
Eukarion, Inc., 6F Alfred Circle, Bedford, Massachusetts 01730, USA. J Med Chem. 2002 Sep 26;45(20):4549-58.

BioNews Results for Eukarion Incorporated:

Proteome exits therapy biz
Drug Discovery News:  Sep 28 2008 3:17AM Matching: eukarion
Proteome Systems Strengthens Focus on Diagnostics and Exits Therapeutics Business
Pharma Live:  Aug 22 2008 1:44PM Matching: eukarion

Eukarion Incorporated Patents:

US Patent No.Title
7122537 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
5696109 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
5827880 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
5834509 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
6046188 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

View more Eukarion Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 209 times since April 2007, the link to the organisation's website has been followed 61 times

Recent Search Terms used to find this page: eukarion | eukarion | Eukarion | Eukarion USA | Eukarion USA | eukarion | Eukarion | Eukarion Incorporated | Eukarion -134 | Eukarion 8 structure | .

Search for more companies in Bedford

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Eukarion Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.